version="1.0" encoding="UTF-8"? version="1.0" encoding="UTF-8"? Sub-navigation Navigation links - Current: Sub-navigation - [ Published Studies by MeVac ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/published-studies) - [ For Collaborators ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/collaborators) - [ General Information about Vaccines ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/general) - [ Participation in Research ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/participation) - [ Published Studies by MeVac ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/published-studies) - [ For Collaborators ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/collaborators) - [ General Information about Vaccines ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/general) - [ Participation in Research ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/participation) # For Collaborators Our facilities are designed for clinical vaccine research. We operate within the Meilahti hospital area as part of HUS, enabling various solutions to serve vaccine research. ## As part of Finland's largest hospital we offer a multitude of benefits - Excellent location in Helsinki at the Meilahti hospital area - Serving a population of 2.2 million in the operational area - Approximately 700,000 patients treated annually within HUS - As HUS offers the whole of Finland specialty care for rare and demanding diseases, special population groups can be included in the studies - HUS hospitals handle around 16,000 deliveries annually, enabling expectant mothers and young children to be reached by targeted invitations to studies - With 27,000 research-friendly and healthy employees, HUS can motivate participation through internal communication channels - Depending on the current needs, specialist doctors and other experts from all medical specialties can be requested to participate in research ## Patient Information System Benefits Research - Precise data can be extracted from the Apotti (EPIC) patient information system - Real-time data on hospital admissions can be used to closely monitor the study participants’ health status - Electronic consent can be requested and signed on the Terveyskylä Omapolku portal - Samples can be obtained through the hospital laboratory’s (HUSLAB) sample storage ## Storage of Vaccines and Samples - Stored at either +4°C, -20°C, or -80°C - Equipment temperatures are monitored - Backup power-connected refrigeration ensures reliable storage for vaccines and samples ## Sample Collection - Blood, urine, and stool samples, as well as skin and mucous membrane swabs and skin biopsies, can be collected at the centre - Samples are processed and stored at the centre - Sample collection can be arranged with HUSLAB according to specific requirements ## Contracts, Budget, and Invoicing Contracts and financial matters are managed through the HYKS Institute. To access their webpage, [please click here](https://hyksinstituutti.fi/en/). ## Contact Us Meilahti Vaccine Research Center (MeVac) tel. +358 50 311 6365 **Address:** Biomedicum Helsinki 1 Haartmaninkatu 8 00290 Helsinki Updated: 10.11.2025 Print this page